These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3810743)

  • 1. The effect of ergotamine and dihydroergotamine on cerebral blood flow in man.
    Andersen AR; Tfelt-Hansen P; Lassen NA
    Stroke; 1987; 18(1):120-3. PubMed ID: 3810743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.
    den Boer MO; Heiligers JP; Saxena PR
    Br J Pharmacol; 1991 Sep; 104(1):183-9. PubMed ID: 1664762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The action of ergotamine on the intracranial venous pressure and on the cerebral venous outflow of the dog.
    CARPI A; VIRNO M
    Br J Pharmacol Chemother; 1957 Jun; 12(2):232-9. PubMed ID: 13446379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro.
    Looper ML; Edrington TS; Moubarak AS; Callaway TR; Rosenkrans CF
    Foodborne Pathog Dis; 2008 Oct; 5(5):599-604. PubMed ID: 18681792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs.
    Diener HC; Peters C; Rudzio M; Noe A; Dichgans J; Haux R; Ehrmann R; Tfelt-Hansen P
    J Neurol; 1991 Aug; 238(5):245-50. PubMed ID: 1655985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
    Roquebert J; Grenié B
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):30-7. PubMed ID: 2881518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve.
    Tfelt-Hansen P; Eickhoff JH; Olesen J
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):151-6. PubMed ID: 7435199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergotamine and cerebral blood flow.
    Hachinski V; Norris JW; Edmeads J; Cooper PW
    Stroke; 1978; 9(6):594-6. PubMed ID: 741494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD
    Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
    Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
    Aellig WH
    Cardiology; 1976; 61 suppl 1():302-8. PubMed ID: 975144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergotamine and dihydroergotamine enhance guanylate cyclase activity.
    Vesely DL
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):245-54. PubMed ID: 6136069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.
    den Boer MO; Somers JA; Saxena PR
    Br J Pharmacol; 1992 Oct; 107(2):577-83. PubMed ID: 1330188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.
    Glusa E; Roos A
    Br J Pharmacol; 1996 Sep; 119(2):330-4. PubMed ID: 8886417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
    Silberstein SD; McCrory DC
    Headache; 2003 Feb; 43(2):144-66. PubMed ID: 12558771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary observations on the influence of ergotamine and dihydroergotamine on cerebral blood flow in the dog.
    ABREU BE; LIDDLE GW
    Fed Proc; 1947; 6(1):304. PubMed ID: 20343633
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of migraine drugs on cerebral blood flow autoregulation.
    Vraamark T; Waldemar G; Paulson OB
    Cephalalgia; 1998; 18(6):306-12. PubMed ID: 9731933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed.
    Aellig WH; Berde B
    Br J Pharmacol; 1969 Jul; 36(3):561-70. PubMed ID: 5789809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.
    Tfelt-Hansen P; Seidelin K; Stepanavage M; Lines C
    Br J Clin Pharmacol; 2002 Jul; 54(1):38-44. PubMed ID: 12100223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ergotamine and dihydroergotamine on 5-hydroxytryptamine-2A receptors in the isolated rat aorta.
    Kalkman HO; Schneider F
    Pharmacology; 1996 Dec; 53(6):351-5. PubMed ID: 9032799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.